Sekwon Jang, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Replimune
    Date added:
    07/24/2023
    Date updated:
    07/08/2024
    Relationship end date:
    06/02/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Merck
    Date added:
    07/08/2024
    Date updated:
    07/08/2024
    Relationship end date:
    05/22/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Novartis
    Date added:
    07/08/2024
    Date updated:
    07/08/2024
    Relationship end date:
    06/25/2024
Return to 2024 Inova Melanoma and Cutaneous Oncology Conference 09/11/2024